Create a management protocol for sepsis in the ICU
sepsis ICU management protocol diagnosis criteria Surviving Sepsis Campaign
sepsis resuscitation fluid therapy vasopressors hemodynamic targets
sepsis antibiotic therapy source control empiric broad spectrum
septic shock organ support mechanical ventilation renal replacement corticosteroids
| Term | Definition |
|---|---|
| Sepsis | Life-threatening organ dysfunction caused by a dysregulated host response to infection (SOFA score increase ≥2 points) |
| Septic Shock | Sepsis + vasopressor requirement to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation |
| qSOFA (bedside screen) | RR ≥22/min, altered mentation, SBP ≤100 mmHg — ≥2 points warrants further evaluation |
Sepsis and septic shock are emergencies. All steps should be initiated simultaneously.
| Consideration | Recommendation |
|---|---|
| Fluid type | Balanced crystalloids (Lactated Ringer's) preferred; normal saline is acceptable |
| Initial bolus | 30 mL/kg IV crystalloid within 3 hours |
| Avoid | Hydroxyethyl starches (HES), gelatins |
| Reassessment | Dynamic measures of fluid responsiveness (pulse pressure variation, stroke volume variation, passive leg raise test) after initial bolus |
| Lactate-guided | Target lactate normalization (<2 mmol/L) as a resuscitation endpoint |
Avoid fluid overload — reassess after each bolus using clinical and hemodynamic parameters. A conservative fluid strategy post-resuscitation is associated with improved outcomes.
| Agent | Role | Notes |
|---|---|---|
| Norepinephrine | First-line vasopressor | Target MAP ≥65 mmHg; higher targets (80–85) may benefit select patients (chronic HTN) |
| Vasopressin | Add-on to reduce NE dose | 0.03–0.04 units/min; do not use as sole agent |
| Epinephrine | Second-line add-on | When NE + vasopressin insufficient |
| Dopamine | Avoid in most cases | Only in select bradycardic patients at low risk of tachyarrhythmia |
| Dobutamine | Cardiac output support | Add to vasopressor if myocardial dysfunction with evidence of tissue hypoperfusion |
| Phenylephrine | Avoid in septic shock | May worsen cardiac output |
| Clinical Scenario | Suggested Regimen |
|---|---|
| Community-acquired (unknown source) | Piperacillin-tazobactam + vancomycin |
| Hospital/ICU-acquired | Meropenem or imipenem ± vancomycin ± antifungal |
| Neutropenic/immunocompromised | Anti-pseudomonal beta-lactam + vancomycin ± antifungal |
| Suspected MRSA | Add vancomycin or linezolid |
| Suspected fungal (Candida) | Add echinocandin (micafungin, caspofungin) |
| Abdominal source | Piperacillin-tazobactam or meropenem (anaerobic coverage) |
| Meningitis | Ceftriaxone + vancomycin + dexamethasone ± ampicillin (Listeria risk) |
| Parameter | Target/Recommendation |
|---|---|
| Mechanical ventilation | For sepsis-induced ARDS (PaO₂/FiO₂ <300) |
| Tidal volume | 6 mL/kg predicted body weight (lung-protective) |
| Plateau pressure | ≤30 cmH₂O |
| PEEP | Titrate to optimize oxygenation; high PEEP strategy for moderate-severe ARDS |
| Prone positioning | For PaO₂/FiO₂ <150 despite optimization — ≥16 hours/day |
| SpO₂ target | 92–96% |
| Conservative O₂ | Avoid hyperoxia (SpO₂ >96% without indication) |
| Parameter | Target/Recommendation |
|---|---|
| Blood glucose | 140–180 mg/dL; use insulin infusion protocol |
| Avoid hypoglycemia | Monitor glucose every 1–2 hours when on insulin infusion |
| Corticosteroids | Hydrocortisone 200 mg/day IV (continuous or 50 mg q6h) if septic shock not responsive to adequate fluids + vasopressors |
| Sodium bicarbonate | Consider if pH <7.15 with AKI (not for lactic acidosis alone) |
| Parameter | Target |
|---|---|
| MAP | ≥65 mmHg |
| Serum lactate | <2 mmol/L (normalize within 6 hours) |
| Urine output | ≥0.5 mL/kg/hr |
| CVP | 8–12 mmHg (12–15 if mechanically ventilated) |
| Central venous O₂ sat (ScvO₂) | ≥70% |
| Capillary refill time | <3 seconds |
| SpO₂ | 92–96% |
Hour 0–1:
□ Measure serum lactate
□ Blood cultures ×2 before antibiotics
□ Administer broad-spectrum antibiotics
□ Begin IV crystalloid 30 mL/kg
□ Start norepinephrine if MAP <65 despite fluids
Hours 1–6:
□ Re-measure lactate if initial >2 mmol/L
□ Reassess volume status (echo, dynamic measures)
□ Identify and control infectious source
□ Initiate organ support (ventilation, RRT as needed)
□ Begin insulin protocol if glucose >180 mg/dL
□ DVT + stress ulcer prophylaxis
Ongoing:
□ Daily reassessment and antibiotic de-escalation
□ Corticosteroids if refractory vasopressor-dependent shock
□ Nutritional support
□ Rehabilitative care planning